Ology Bioservices, Inovio Partner To Manufacture COVID-19 DNA Vaccine With $11.9 Million Department of Defense Grant
UF Innovate | Sid Martin Biotech alum Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), and Inovio Pharmaceuticals Inc., a company developing DNA medicines for infectious diseases and cancer, announced that the Department of Defense (DOD) has awarded Ology Bioservices with a contract valued at $11.9 million to work with Inovio on […]
Ology Bioservices, Vanderbilt University Medical Center to Develop, Manufacture Monoclonal Antibody for Treatment, Prevention of Infection With COVID-19 Virus for Department of Defense
The Department of Defense (DOD) awarded a contract valued at $14 million with UF Innovate | Sid Martin Biotech alum Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), to develop and manufacture a monoclonal antibody for treatment and prevention of infection with the COVID-19 virus. This work is supported by the Office […]
Ology Bioservices, Inc. Will Receive $9 Million of Funding to Support Manufacturing of Nipah Virus Vaccine
The Coalition for Epidemic Preparedness Innovations (CEPI) will provide $43.6 million to advance the development and manufacture of the rVSV-Nipah vaccine candidate against the Nipah virus. UF startup Ology Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), will receive $9M to support the manufacturing and stockpiling of the rVSV-Nipah vaccine. The Nipah virus, […]
Blue Water Vaccines, Developing Universal Flu Vaccine, to Partner With Ology Bioservices Inc.
Blue Water Vaccines, a Cincinnati-based biotechnology startup, has signed an agreement with UF startup Ology Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), to manufacture a novel universal influenza vaccine. The vaccine, based on technology licensed from the prestigious University of Oxford in the U.K., has shown promising results in a preclinical study […]
Ology Bioservices Wins Two Department of Defense Awards Totaling More Than $135 Million
UF startup Ology Bioservices, Inc., a biologics contract development and manufacturing organization, has announced that the Department of Defense (DOD), through its Platforms for Rapid Integrated Solutions for Medical Countermeasures (PRISM) office, has awarded the company with two contracts valued at $135.4 million. The first is for the development of a medical countermeasure, and the […]
Ology Bioservices Wins Two Department of Defense Awards Totaling More Than $135 Million
UF startup Ology Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), announced that the Department of Defense (DOD), through its Platforms for Rapid Integrated Solutions for Medical Countermeasures (PRISM) office, has awarded the company with two contracts valued at $135.4 million. The first is for the development of a medical countermeasure, and the […]
Ology Bioservices Appoints Vaccines and Biologics Manufacturing Industry Veteran, Brandon Brega, as Chief Operating Officer
UF startup Ology Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), announced the appointment of vaccines and biologics manufacturing industry expert, Brandon Brega, to the position of Chief Operating Officer, effective immediately. In this newly created position, Brandon will lead manufacturing and operations at the company’s 183,000 square foot Department of Defense Advanced […]
Ology Bioservices Wins $8.4 Million Defense Department Award to Produce Anti-Ebola Medical Countermeasure (BioFlorida)
UF startup and UF Innovate | Sid Martin Biotech alumn Ology Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), announced that it was awarded an Other Transaction Agreement (OTA) to support the Joint Project Manager Medical Countermeasure Systems (JPM-MCS), a component of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear […]
Ology Bioservices and RAFA Laboratories Announce FDA Approval of the Atropine Autoinjector as a Medi (BioFlorida)
UF startup and Sid Martin Biotech alum Ology Bioservices, Inc., a biologics contract development and manufacturing organization, and Rafa Laboratories, Ltd., a leading Israeli pharmaceutical company, announced that on July 9, 2018, they received full approval from the U.S. Food and Drug Administration (FDA) for the Atropine Injection, 2mg/0.7mL, Single-Dose Autoinjector. The Atropine Autoinjector initially […]